Literature DB >> 3009557

Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man.

A K Ghosh, M Moore, M Harris.   

Abstract

The monoclonal antibody RAP-5 generated against a synthetic peptide corresponding to amino acid positions 10-17 of the ras p21 protein was used in an immunohistochemical study of the expression of ras in normal, benign, and malignant breast epithelium in man. The staining intensity and intracellular distribution of RAP-5 was similar in the three epithelial populations and extended to other tissue elements including myoepithelial cells, smooth muscle, myelin, capillary endothelium, and stromal fibroblasts, as well as sebaceous glands and sweat glands overlying the breast. These results suggest that RAP-5 recognises a normal cellular component, the expression of which is not more enhanced in hyperplastic or neoplastic conditions. The detection of mutant forms of p21 exclusively expressed in malignant tumours requires that alternative reagents be developed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009557      PMCID: PMC499840          DOI: 10.1136/jcp.39.4.428

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  24 in total

1.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

Review 2.  Cancer genes come of age.

Authors:  J M Bishop
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

3.  Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue.

Authors:  D J Capon; E Y Chen; A D Levinson; P H Seeburg; D V Goeddel
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

4.  Oncogenes in solid human tumours.

Authors:  S Pulciani; E Santos; A V Lauver; L K Long; S A Aaronson; M Barbacid
Journal:  Nature       Date:  1982-12-09       Impact factor: 49.962

5.  Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins.

Authors:  T Kamata; J R Feramisco
Journal:  Nature       Date:  1984 Jul 12-18       Impact factor: 49.962

6.  Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas.

Authors:  C J Der; G M Cooper
Journal:  Cell       Date:  1983-01       Impact factor: 41.582

7.  Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene.

Authors:  L F Parada; C J Tabin; C Shih; R A Weinberg
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

8.  Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistry.

Authors:  M C Willingham; I Pastan; T Y Shih; E M Scolnick
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

9.  Elevated expression of the human ras oncogene family in premalignant and malignant tumours of the colorectum.

Authors:  D A Spandidos; I B Kerr
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

10.  Immunocytochemical demonstration of p21 ras family oncogene product in normal mucosa and in premalignant and malignant tumours of the colorectum.

Authors:  I B Kerr; F D Lee; M Quintanilla; A Balmain
Journal:  Br J Cancer       Date:  1985-11       Impact factor: 7.640

View more
  8 in total

1.  Immunocytochemical localization of ras p21 product in thyroid follicular cells of normal rats using monoclonal antibody RAP-5.

Authors:  Y Mizukami; A Nonomura; T Hashimoto; E Kawahara; S Matsukawa; F Matsubara
Journal:  Histochem J       Date:  1988-11

Review 2.  Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Authors:  David N Danforth
Journal:  Breast Cancer (Auckl)       Date:  2016-08-17

3.  Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9.

Authors:  D C Allen; H Foster; J C Orchin; J D Biggart
Journal:  J Clin Pathol       Date:  1987-02       Impact factor: 3.411

4.  Evaluation of a monoclonal antibody to ras peptide, RAP-5, claimed to bind preferentially to cells of infiltrating carcinomas.

Authors:  A Robinson; A R Williams; J Piris; D A Spandidos; A H Wyllie
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

5.  A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer.

Authors:  D J Jones; A K Ghosh; M Moore; P F Schofield
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

6.  Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer.

Authors:  Shuang Bai; Qiang Feng; Xin-Yan Pan; Hong Zou; Hao-Bin Chen; Peng Wang; Xin-Liang Zhou; Yan-Ling Hong; Shu-Ling Song; Ju-Lun Yang
Journal:  Int J Mol Med       Date:  2017-02-21       Impact factor: 4.101

7.  Reactivity of monoclonal antibodies to oncoproteins with normal rat liver, carcinogen-induced tumours, and premalignant liver lesions.

Authors:  M J Embleton; P C Butler
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

8.  Ras p21 in breast tissue: associations with pathology and cellular localisation.

Authors:  J J Going; T J Anderson; A H Wyllie
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.